These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7986734)

  • 1. Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy?
    Cook G; Walker ID; McCall F; Conkie JA; Greer IA
    Br J Haematol; 1994 Aug; 87(4):873-5. PubMed ID: 7986734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):51-7. PubMed ID: 8180338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
    Dahlbäck B; Carlsson M; Svensson PJ
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1004-8. PubMed ID: 8430067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C resistance--a recently discovered hereditary thrombophilia].
    Moland L; Sandset PM
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
    Alving BM; Comp PC
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.
    Koster T; Rosendaal FR; de Ronde H; Briët E; Vandenbroucke JP; Bertina RM
    Lancet; 1993 Dec 18-25; 342(8886-8887):1503-6. PubMed ID: 7902898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombophilia in a family with resistance to activated protein C and protein S deficiency].
    Lewandowski K; Turowiecka Z; Zawilska K
    Pol Arch Med Wewn; 1995 Dec; 94(6):518-24. PubMed ID: 8618815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and patient profile in activated protein C resistance.
    Samaha M; Trossaert M; Conard J; Horellou MH; Elalamy I; Samama MM
    Am J Clin Pathol; 1995 Oct; 104(4):450-4. PubMed ID: 7572797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia.
    Sun X; Evatt B; Griffin JH
    Blood; 1994 Jun; 83(11):3120-5. PubMed ID: 8193349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free protein S deficiency in a family with venous thrombosis.
    Lauer CG; Reid TJ; Wideman CS; Evatt BL; Alving BM
    J Vasc Surg; 1990 Nov; 12(5):541-4. PubMed ID: 2146406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.
    Hellgren M; Svensson PJ; Dahlbäck B
    Am J Obstet Gynecol; 1995 Jul; 173(1):210-3. PubMed ID: 7631684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.